Advocates ‘thrilled’ by state decision to cap spending on diabetes drug Jardiance Health care advocates on Wednesday hailed recent steps to limit how much state health plans will pay for a popular a Type 2 diabetes drug, a move that could save state and local governments an estimated $320,000 a year.